The 7HC project is in the field of application concerning the development of new drugs, their repositioning or the development of nutritional supplements which has always been driven by an intense interdisciplinary effort.
This process begins with the identification of biological targets, and continues with the design and optimization of the candidate molecules until the pre-clinical “in vitro” and “in vivo” phase that determines whether the candidate compounds meet a set of criteria for the start of clinical development.
The need for resource optimization is evident when one considers that on average 12-14 years and over 1 billion euros are required to bring a drug to market from the moment of its discovery.
Currently the development process of a molecule is characterized by a very high number of failures, largely due to inadequate pharmacokinetics, lack of efficacy, toxicity, side effects in humans and various commercial factors.
7HC fits into this context with an integrated software platform for the in silico prediction of pharmacological efficacy.
The 7HC algorithm, already developed and tested by the designers of the project, is able to make an estimation of parameters of extreme importance to guide the initial design and optimization of a drug by strongly reducing the in vitro tests with extremely high costs (thousands of euros per molecule).